- Report
- May 2025
- 184 Pages
Global
From €5325EUR$5,850USD£4,473GBP
- Report
- May 2025
- 179 Pages
Global
From €5325EUR$5,850USD£4,473GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,433GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,433GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,433GBP
- Report
- August 2024
- 145 Pages
Global
From €2730EUR$2,999USD£2,293GBP
- Report
- August 2024
- 148 Pages
Global
From €2730EUR$2,999USD£2,293GBP
- Report
- September 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- August 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- August 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- July 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- June 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- July 2024
- 200 Pages
Global
From €4505EUR$4,949USD£3,784GBP
- Report
- July 2024
- 100 Pages
Global
From €3414EUR$3,750USD£2,867GBP
- Report
- November 2024
- 219 Pages
Global
From €2276EUR$2,500USD£1,912GBP
- Report
- July 2024
- 186 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- May 2025
- 120 Pages
Global
From €4324EUR$4,750USD£3,632GBP
- Report
- February 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- February 2025
- 188 Pages
Global
From €4096EUR$4,500USD£3,441GBP
- Report
- August 2024
- 184 Pages
Global
From €4096EUR$4,500USD£3,441GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more